Showing 5,181 - 5,200 results of 5,382 for search '"translated"', query time: 0.08s Refine Results
  1. 5181
  2. 5182
  3. 5183
  4. 5184
  5. 5185
  6. 5186

    Establishing an Electrophysiological Recording Platform for Epidural Spinal Cord Stimulation in Neuropathic Pain Rats by Yang CT, Shyu BC, Lin WT, Lu KH, Lin CR, Wen YR, Chen CC

    Published 2025-01-01
    “…., New Taipei City, Taiwan; 5Department of Anesthesiology, National Cheng Kung University Hospital, Tainan, Taiwan; 6Pain Management and Research Center, Department of Anesthesiology, China Medical University Hospital, Taichung, Taiwan; 7Chun Chuan Orthopedic and Pain Specialty Hospital, Taichung, Taiwan; 8Pain Management Center, Department of Anesthesiology, Jen-Ai General Hospital, Taichung, Taiwan; 9Neuroscience Program of Academia Sinica, Academia Sinica, Taipei, Taiwan; 10Taiwan Mouse Clinic, Biomedical Translational Research Center, Academia Sinica, Taipei, Taiwan*These authors contributed equally to this workCorrespondence: Chih-Cheng Chen; Yeong-Ray Wen, Email chih@ibms.sinica.edu.tw; yray.wen@gmail.comPurpose: Spinal cord stimulation (SCS) is pivotal in treating chronic intractable pain. …”
    Get full text
    Article
  7. 5187
  8. 5188
  9. 5189
  10. 5190
  11. 5191
  12. 5192
  13. 5193
  14. 5194
  15. 5195
  16. 5196
  17. 5197
  18. 5198

    The importance of specific exercise therapy in pediatric oncology by Bianca Celine Schmidli, Céline Hammadou, Christina Schindera, Nicolas von der Weid, Uta Tacke, Oliver Faude, Sarah Koch, Fiona Streckmann

    Published 2025-01-01
    “…The international pediatric oncology exercise guidelines (iPOEG). Translational Behavioral Medicine, 11(10), 1915–1923. https://doi.org/10.1093/tbm/ibab028 …”
    Get full text
    Article
  19. 5199

    Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Mult... by Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W

    Published 2025-01-01
    “…Yujing Tan,1,* Hanfang Jiang,2,* Xinzhu Tian,1,* Fei Ma,1 Jiayu Wang,1 Pin Zhang,1 Binghe Xu,1 Ying Fan,1 Weihong Zhao3 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, People’s Republic of China; 3Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ying Fan; Weihong Zhao, Email fanying@cicams.ac.cn; zhaowh0818@163.comPurpose: This study aims to explore the role of the non-luminal disease score (NOLUS) for everolimus in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC).Methods: NOLUS has previously been established as an algorithm: NOLUS (0– 100) = − 0.45 × ER(%) − 0.28 × PR(%) + 0.27 × Ki67(%) + 73. …”
    Get full text
    Article
  20. 5200